This study demonstrates in both stable and inducible BCR-ABL-expressing hem
atopoietic cells a down-regulation of the major mammalian DNA repair protei
n DNA-PKcs by BCR-ABL. Similar results were found in BCR-ABL CD34(+) cells
from patients with chronic myelogenous leukemia (CML), DNA-PKcs down-regula
tion is a proteasome-dependent degradation that requires tyrosine kinase ac
tivity and is associated with a marked DNA repair deficiency along with inc
reased sensitivity to ionizing radiation, The conjunction of a major DNA re
pair deficiency and a resistance to apoptosis, both induced by BCR-ABL, pro
vides a new mechanism to explain how secondary genetic alterations can accu
mulate in CML, eventually leading to blast crisis. The down-regulation of D
NA-PKcs was reversible in CD34(+) CML cells suggesting that this approach m
ight offer a novel and powerful therapeutic strategy in this disease, espec
ially to delay the blast crisis.